On October 1, 2016, the 1-year anniversary of ICD-10
implementation, the grace period extended by the Centers for
Medicare and Medicaid Services (CMS) for ICD-10 flexibility on
physician and practitioner claims is set to end.
ICD-10 was implemented on October 1, 2015. Prior to its
implementation, on July 6, 2015, after months of significant
pressure from the American Medical Association (AMA) and other
physicians groups, CMS announced flexibility in its enforcement of
physician and practitioner claims. As reported on the
McDermottPlus website, CMS announced that for the first 12 months after
ICD-10 implementation, physician or other practitioner claims
billed under the Part B physician fee schedule will not be denied
solely on the specificity of the ICD-10 diagnosis code as long as a
code from the right family is used.
In a recently updated FAQ document posted on the CMS website, CMS
confirmed that they will not extend this flexibility beyond October
1, 2016. CMS states in the guidance, "As of October 1, 2016,
providers will be required to code to accurately reflect the
clinical documentation in as much as specificity as possible, per
the required coding guidance."
CMS noted in the FAQ, that while the coding flexibility offered
in the first year of ICD-10 implementation may have been helpful to
many providers, since not all insurers offered this flexibility,
some providers are already using specific codes.
The transition to ICD-10, which created anxiety throughout the
healthcare industry, was fraught with multiple delays and took
years to come to fruition. Despite the many dire predictions of
chaos that would result from ICD-10 implementation, by most
accounts the first year has been generally smooth and CMS did not
experience a significant uptick in denials. With the end of the
flexibility period looming, there remains concern that some
practices still are not ready and the end of the flexibility could
cause an increase in denied claims and as a result disruptions in
Whatever happens after October 1, 2016, ICD-10 compliance and
claim denial rates will be closely monitored by CMS and numerous
stakeholder groups. McDermottPlus will continue to monitor the
Remember how Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996), dismissed the §510k "substantially equivalence" medical device clearance as non-preemptive because it was supposedly "focused on equivalence, not safety"? Id. at 493.
The US Food and Drug Administration (FDA) related portions of the 21st Century Cares Act, found in title III, establish a streamlined process for the exemption of certain Class I and II devices from the premarket notification requirement and allow for the establishment of revised regulatory standards for accessories to high-risk devices.
Hospitals are commonly named as defendants in medical malpractice lawsuits for claims arising from alleged injuries within their walls, but what is their exposure to liability for claims that arise from alleged sexual assaults by staff on their premises?
Eric Fader was quoted in a November 9 article, "Incoming Trump Administration May Mean Less Funding for HIPAA Audits," in Bloomberg BNA's Health Care Fraud Report. Eric said that the incoming Trump administration may eventually be forced to reduce funding for some healthcare initiatives to pay for other priorities, such as large tax cuts and increased spending on the military.
Title III of the 21st Century Cures Act includes portions of the FDA Device Accountability Act of 2015, Promoting Biomedical Research and Public Health for Patients Act, and FDA and NIH Workforce Authorities Modernization Act.
A February 2 article in Bloomberg BNA's Privacy Law Watch and other publications, "Hospital Hit With $3.2M Penalty for Ongoing Health Data Security Lapses," reported that Children's Medical Center of Dallas received a $3.2 million civil money penalty after years of noncompliance with HIPAA rules and after failing to request a hearing on the penalty.
The 21st Century Cures Act includes portions of the Helping Families in Mental Health Crisis Reform Act of 2016, which was approved by the US House of Representatives in July 2016, but not advanced by the Senate.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).